Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature
- PMID: 31307867
- DOI: 10.1016/j.diagmicrobio.2019.06.008
Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature
Abstract
Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR) bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 hours and 14 days, respectively. Response rates did not vary across pathogens. Our retrospective, observational findings support fosfomycin treatment against MDR pathogens causing UTIs.
Keywords: CRE; ESBL; Fosfomycin; UTI; VRE.
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment in
-
Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection.Diagn Microbiol Infect Dis. 2020 Mar;96(3):114961. doi: 10.1016/j.diagmicrobio.2019.114961. Epub 2019 Dec 4. Diagn Microbiol Infect Dis. 2020. PMID: 31859021 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
